Related Experiment Video
Updated: Jul 20, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Drug-Repurposing Strategy for Dimethyl Fumarate
Salvatore Giunta1, Agata Grazia D'Amico2, Grazia Maugeri1
1Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
Dimethyl fumarate (DMF), an approved drug, shows potential in treating diabetic retinopathy (DR). DMF treatment reduced key inflammatory markers in a rat model, suggesting a protective effect against DR progression.
Area of Science:
- Ophthalmology
- Pharmacology
- Drug Discovery
Background:
- Diabetic retinopathy (DR) is a complication of diabetes, leading to vision impairment.
- Current treatments for DR focus on managing blood sugar and intraocular pressure.
- Drug repurposing offers a strategy to find new therapeutic applications for existing medications.
Purpose of the Study:
- To investigate the potential of dimethyl fumarate (DMF) in treating early diabetic retinopathy (DR).
- To evaluate the effects of DMF on key molecular markers associated with DR pathogenesis.
Main Methods:
- A streptozotocin (STZ)-induced diabetic rat model was used.
- Animals received daily intraperitoneal injections of DMF or vehicle.
- Retinal expression of COX-2, iNOS, and HO-1 was analyzed using Western blot and immunohistochemistry.
Main Results:
- Diabetic rats exhibited elevated retinal COX-2 and iNOS levels, with increased HO-1.
- DMF treatment significantly upregulated HO-1 expression in diabetic rat retinas.
- DMF administration led to a reduction in retinal iNOS and COX-2 levels.
Conclusions:
- Dimethyl fumarate (DMF) may counteract the inflammatory and oxidative stress associated with diabetic retinopathy (DR).
- DMF demonstrates potential as a therapeutic agent for DR.
- Further in vivo and clinical studies are warranted to confirm DMF's efficacy in treating DR.
More Related Videos
Related Concept Videos
Prodrugs
Prodrugs help overcome...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Phase I Reactions: Reductive Reactions
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Regulation
Drug Biotransformation: Overview

